Clinical Trial Update: GLP-1 Response in Women With PCOS and Prediabetes [NA]

View source ↗

Summary

A clinical trial evaluating GLP-1 response in women with polycystic ovary syndrome and prediabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome
• Prediabetes

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Incretin Hormones in PCOS With Prediabetes | NA | Status: COMPLETED